TY - JOUR
T1 - Genetic and geographic influence on phenotypic variation in European sarcoidosis patients
AU - Freitag-Wolf, Sandra
AU - Schupp, Jonas C.
AU - Frye, Björn C.
AU - Fischer, Annegret
AU - Anwar, Raihanatul
AU - Kieszko, Robert
AU - Mihailović-Vučinić, Violeta
AU - Milanowski, Janusz
AU - Jovanovic, Dragana
AU - Zissel, Gernot
AU - Bargagli, Elena
AU - Rottoli, Paola
AU - Bumbacea, Dragos
AU - Jonkers, René
AU - Ho, Ling-Pei
AU - Gaede, Karoline I.
AU - Dubaniewicz, Anna
AU - Marshall, Ben G.
AU - Günther, Andreas
AU - Petrek, Martin
AU - Keane, Michael P.
AU - Haraldsdottir, Sigridur O.
AU - Bonella, Francesco
AU - Grah, Christian
AU - Peroš-Golubičić, Tatjana
AU - Kadija, Zamir
AU - Pabst, Stefan
AU - Grohé, Christian
AU - Strausz, J. nos
AU - Safrankova, Martina
AU - Millar, Ann
AU - Homolka, Jiří
AU - Wuyts, Wim A.
AU - Spencer, Lisa G.
AU - Pfeifer, Michael
AU - Valeyre, Dominique
AU - Poletti, Venerino
AU - Wirtz, Hubertus
AU - Prasse, Antje
AU - Schreiber, Stefan
AU - Dempfle, Astrid
AU - Müller-Quernheim, Joachim
N1 - Funding Information: This study was supported by German Federal Ministry for Education and Research grant 01EY1103 and German Research Foundation grant MU 692/8-1 and FI 1935/1-1, DFG Exzellenzcluster PMI EXC 2/67 and Clusterlab XI EXC 306/2. JCS is supported by the CORE100Pilot Advanced Clinician Scientist Program of Hannover Medical School funded by Else Kröner-Fresenius Foundation (2020_EKSP.78) and the Ministry of Science and Culture of Lower Saxony, and the Fritz Thyssen-Foundation. Publisher Copyright: Copyright © 2023 Freitag-Wolf, Schupp, Frye, Fischer, Anwar, Kieszko, Mihailović-Vučinić, Milanowski, Jovanovic, Zissel, Bargagli, Rottoli, Bumbacea, Jonkers, Ho, Gaede, Dubaniewicz, Marshall, Günther, Petrek, Keane, Haraldsdottir, Bonella, Grah, Peroš-Golubičić, Kadija, Pabst, Grohé, Strausz, Safrankova, Millar, Homolka, Wuyts, Spencer, Pfeifer, Valeyre, Poletti, Wirtz, Prasse, Schreiber, Dempfle and Müller-Quernheim.
PY - 2023
Y1 - 2023
N2 - Introduction: Sarcoidosis is a highly variable disease in terms of organ involvement, type of onset and course. Associations of genetic polymorphisms with sarcoidosis phenotypes have been observed and suggest genetic signatures. Methods: After obtaining a positive vote of the competent ethics committee we genotyped 1909 patients of the deeply phenotyped Genetic-Phenotype Relationship in Sarcoidosis (GenPhenReSa) cohort of 31 European centers in 12 countries with 116 potentially disease-relevant single-nucleotide polymorphisms (SNPs). Using a meta-analysis, we investigated the association of relevant phenotypes (acute vs. sub-acute onset, phenotypes of organ involvement, specific organ involvements, and specific symptoms) with genetic markers. Subgroups were built on the basis of geographical, clinical and hospital provision considerations. Results: In the meta-analysis of the full cohort, there was no significant genetic association with any considered phenotype after correcting for multiple testing. In the largest sub-cohort (Serbia), we confirmed the known association of acute onset with TNF and reported a new association of acute onset an HLA polymorphism. Multi-locus models with sets of three SNPs in different genes showed strong associations with the acute onset phenotype in Serbia and Lublin (Poland) demonstrating potential region-specific genetic links with clinical features, including recently described phenotypes of organ involvement. Discussion: The observed associations between genetic variants and sarcoidosis phenotypes in subgroups suggest that gene–environment-interactions may influence the clinical phenotype. In addition, we show that two different sets of genetic variants are permissive for the same phenotype of acute disease only in two geographic subcohorts pointing to interactions of genetic signatures with different local environmental factors. Our results represent an important step towards understanding the genetic architecture of sarcoidosis.
AB - Introduction: Sarcoidosis is a highly variable disease in terms of organ involvement, type of onset and course. Associations of genetic polymorphisms with sarcoidosis phenotypes have been observed and suggest genetic signatures. Methods: After obtaining a positive vote of the competent ethics committee we genotyped 1909 patients of the deeply phenotyped Genetic-Phenotype Relationship in Sarcoidosis (GenPhenReSa) cohort of 31 European centers in 12 countries with 116 potentially disease-relevant single-nucleotide polymorphisms (SNPs). Using a meta-analysis, we investigated the association of relevant phenotypes (acute vs. sub-acute onset, phenotypes of organ involvement, specific organ involvements, and specific symptoms) with genetic markers. Subgroups were built on the basis of geographical, clinical and hospital provision considerations. Results: In the meta-analysis of the full cohort, there was no significant genetic association with any considered phenotype after correcting for multiple testing. In the largest sub-cohort (Serbia), we confirmed the known association of acute onset with TNF and reported a new association of acute onset an HLA polymorphism. Multi-locus models with sets of three SNPs in different genes showed strong associations with the acute onset phenotype in Serbia and Lublin (Poland) demonstrating potential region-specific genetic links with clinical features, including recently described phenotypes of organ involvement. Discussion: The observed associations between genetic variants and sarcoidosis phenotypes in subgroups suggest that gene–environment-interactions may influence the clinical phenotype. In addition, we show that two different sets of genetic variants are permissive for the same phenotype of acute disease only in two geographic subcohorts pointing to interactions of genetic signatures with different local environmental factors. Our results represent an important step towards understanding the genetic architecture of sarcoidosis.
KW - genetic polymorphism
KW - genetic risk factors
KW - genotype–phenotype-relationship
KW - region-specific genetic links
KW - sarcoidosis
UR - http://www.scopus.com/inward/record.url?scp=85168705652&partnerID=8YFLogxK
U2 - https://doi.org/10.3389/fmed.2023.1218106
DO - https://doi.org/10.3389/fmed.2023.1218106
M3 - Article
C2 - 37621457
SN - 2296-858X
VL - 10
JO - Frontiers in Medicine
JF - Frontiers in Medicine
M1 - 1218106
ER -